VentriJect: Prioritising VO2 Max Testing
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
VentriJect: Prioritising VO2 Max Testing
-
Narrated by:
-
By:
About this listen
In this episode of the Medtech Ventures podcast, Craig Townsend interviews Kasper Sørensen, CTO and co-founder of VentriJect, about the Seismofit, technology for estimating VO2 max.
They discuss Kasper's journey from academia to entrepreneurship, the challenges of developing a medical device, navigating regulatory landscapes, and the importance of VO2 max as a vital sign monitor.
The conversation also explores the future of cardiorespiratory health and AI. Kasper shares valuable insights for aspiring entrepreneurs, emphasizing the importance of pursuing good ideas.
Listen or download our podcast bi-weekly on Thursdays.
Follow Craig on LinkedIn.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.